Sen lim personal page - To The Moon

Sen lim

Sen lim

Abundance

2Follow

2Followers

0Topic

0Badge

2023-12-28

The story will unfold brilliantly in 2024

@VideoLounge: [The Fed has the economy's back in 2024, says Wharton's Jeremy Siegel] Jeremy Siegel, Wharton Professor, joins 'Closing Bell' to discuss the markets, equities and his Fed outlook. $S&P 500(.SPX)$

2023-10-19

2023-10-19

Great ariticle, would you like to share it?

@WallStreet_Tiger:Pharma and Insurance Stocks Hit New Highs With Earnings Beats and Analysts Upgrade!

2023-10-19

Great ariticle, would you like to share it?

@JC888:$BAC Q3 earnings out & there's NOTHING to celebrate.

2023-10-19

Great ariticle, would you like to share it?

@TigerOptions:Celebrating BAC's Earnings with Strangle 🎉

2023-02-05

ORGS - orgenesis MASI - masimo corporation

Go to Tiger App to see more news

{"i18n":{"language":"en_US"},"userPageInfo":{"id":"3575340533089136","uuid":"3575340533089136","gmtCreate":1612260152387,"gmtModify":1710641193266,"name":"Sen lim","pinyin":"senlimsenlim","introduction":"","introductionEn":"","signature":"Abundance","avatar":"https://community-static.tradeup.com/news/8c0dcc765f505fe12d0f172a1ff04c50","hat":"https://static.tigerbbs.com/b0a2963eb37c60c5d6d4a8dbcd266952","hatId":"ca_profile_frame_DWr5S1","hatName":"","vip":1,"status":2,"fanSize":2,"headSize":2,"tweetSize":6,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":1,"name":"萌萌虎","nameTw":"萌萌虎","represent":"呱呱坠地","factor":"评论帖子3次或发布1条主帖（非转发）","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":"success","userBadges":[{"badgeId":"1026c425416b44e0aac28c11a0848493-2","templateUuid":"1026c425416b44e0aac28c11a0848493","name":"Senior Tiger","description":"Join the tiger community for 1000 days","bigImgUrl":"https://static.tigerbbs.com/0063fb68ea29c9ae6858c58630e182d5","smallImgUrl":"https://static.tigerbbs.com/96c699a93be4214d4b49aea6a5a5d1a4","grayImgUrl":"https://static.tigerbbs.com/35b0e542a9ff77046ed69ef602bc105d","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.10.31","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"44212b71d0be4ec88898348dbe882e03-2","templateUuid":"44212b71d0be4ec88898348dbe882e03","name":"Executive Tiger","description":"The transaction amount of the securities account reaches $300,000","bigImgUrl":"https://static.tigerbbs.com/9d20b23f1b6335407f882bc5c2ad12c0","smallImgUrl":"https://static.tigerbbs.com/ada3b4533518ace8404a3f6dd192bd29","grayImgUrl":"https://static.tigerbbs.com/177f283ba21d1c077054dac07f88f3bd","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.07.14","exceedPercentage":"80.65%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101},{"badgeId":"7a9f168ff73447fe856ed6c938b61789-1","templateUuid":"7a9f168ff73447fe856ed6c938b61789","name":"Knowledgeable Investor","description":"Traded more than 10 stocks","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.03.04","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"972123088c9646f7b6091ae0662215be-1","templateUuid":"972123088c9646f7b6091ae0662215be","name":"Elite Trader","description":"Total number of securities or futures transactions reached 30","bigImgUrl":"https://static.tigerbbs.com/ab0f87127c854ce3191a752d57b46edc","smallImgUrl":"https://static.tigerbbs.com/c9835ce48b8c8743566d344ac7a7ba8c","grayImgUrl":"https://static.tigerbbs.com/76754b53ce7a90019f132c1d2fbc698f","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.02.01","exceedPercentage":"60.73%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"a83d7582f45846ffbccbce770ce65d84-1","templateUuid":"a83d7582f45846ffbccbce770ce65d84","name":"Real Trader","description":"Completed a transaction","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":5,"currentWearingBadge":{"badgeId":"44212b71d0be4ec88898348dbe882e03-1","templateUuid":"44212b71d0be4ec88898348dbe882e03","name":"Boss Tiger","description":"The transaction amount of the securities account reaches $100,000","bigImgUrl":"https://static.tigerbbs.com/c8dfc27c1ee0e25db1c93e9d0b641101","smallImgUrl":"https://static.tigerbbs.com/f43908c142f8a33c78f5bdf0e2897488","grayImgUrl":"https://static.tigerbbs.com/82165ff19cb8a786e8919f92acee5213","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":1,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.03.10","exceedPercentage":"60.08%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101},"individualDisplayBadges":null,"crmLevel":1,"crmLevelSwitch":1,"location":null,"starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"post","tweets":[{"id":256917102407696,"gmtCreate":1703757916604,"gmtModify":1703757919870,"author":{"id":"3575340533089136","authorId":"3575340533089136","name":"Sen lim","avatar":"https://community-static.tradeup.com/news/8c0dcc765f505fe12d0f172a1ff04c50","crmLevel":1,"crmLevelSwitch":1,"followedFlag":false,"idStr":"3575340533089136","authorIdStr":"3575340533089136"},"themes":[],"htmlText":"The story will unfold brilliantly in 2024","listText":"The story will unfold brilliantly in 2024","text":"The story will unfold brilliantly in 2024","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/256917102407696","repostId":"256901342552192","repostType":1,"repost":{"id":256901342552192,"gmtCreate":1703749619270,"gmtModify":1703749647446,"author":{"id":"3527667631258507","authorId":"3527667631258507","name":"VideoLounge","avatar":"https://static.tigerbbs.com/d2c50ee53d2487e186b3c414f8529d52","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3527667631258507","authorIdStr":"3527667631258507"},"themes":[],"htmlText":"\n \n \n  [The Fed has the economy's back in 2024, says Wharton's Jeremy Siegel] Jeremy Siegel, Wharton Professor, joins 'Closing Bell' to discuss the markets, equities and his Fed outlook. <a href=\"https://ttm.financial/S/.SPX\">$S&amp;P 500(.SPX)$</a>\n \n","listText":"[The Fed has the economy's back in 2024, says Wharton's Jeremy Siegel] Jeremy Siegel, Wharton Professor, joins 'Closing Bell' to discuss the markets, equities and his Fed outlook. <a href=\"https://ttm.financial/S/.SPX\">$S&amp;P 500(.SPX)$</a>","text":"[The Fed has the economy's back in 2024, says Wharton's Jeremy Siegel] Jeremy Siegel, Wharton Professor, joins 'Closing Bell' to discuss the markets, equities and his Fed outlook. $S&P 500(.SPX)$","images":[],"top":1,"highlighted":1,"essential":2,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/256901342552192","isVote":1,"tweetType":2,"object":{"id":"1bc999e668f64d2585532868777ae90c","tweetId":"256901342552192","videoUrl":"https://1254107296.vod2.myqcloud.com/e2ad4227vodcq1254107296/185c5d1b3270835014349635313/f0.mp4","poster":"https://community-static.tradeup.com/news/8074bcf4d3448aeb6fe42f69c5f6f100"},"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":238,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":232186656051360,"gmtCreate":1697714453110,"gmtModify":1697714800230,"author":{"id":"3575340533089136","authorId":"3575340533089136","name":"Sen lim","avatar":"https://community-static.tradeup.com/news/8c0dcc765f505fe12d0f172a1ff04c50","crmLevel":1,"crmLevelSwitch":1,"followedFlag":false,"idStr":"3575340533089136","authorIdStr":"3575340533089136"},"themes":[],"htmlText":"","listText":"","text":"","images":[{"img":"https://community-static.tradeup.com/news/d737c0e83a2ca20db6a3f699381bb310","width":"1170","height":"3054"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/232186656051360","isVote":1,"tweetType":1,"viewCount":208,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":232186431336688,"gmtCreate":1697714398564,"gmtModify":1697714490534,"author":{"id":"3575340533089136","authorId":"3575340533089136","name":"Sen lim","avatar":"https://community-static.tradeup.com/news/8c0dcc765f505fe12d0f172a1ff04c50","crmLevel":1,"crmLevelSwitch":1,"followedFlag":false,"idStr":"3575340533089136","authorIdStr":"3575340533089136"},"themes":[],"htmlText":"Great ariticle, would you like to share it?","listText":"Great ariticle, would you like to share it?","text":"Great ariticle, would you like to share it?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/232186431336688","repostId":"231579639484416","repostType":1,"repost":{"id":231579639484416,"gmtCreate":1697546525532,"gmtModify":1697546571385,"author":{"id":"9000000000000419","authorId":"9000000000000419","name":"WallStreet_Tiger","avatar":"https://community-static.tradeup.com/news/1fdbba25bcf5dea3f281241ba1320d10","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"9000000000000419","authorIdStr":"9000000000000419"},"themes":[],"title":"Pharma and Insurance Stocks Hit New Highs With Earnings Beats and Analysts Upgrade!","htmlText":"1. Pharma&nbsp;stocks <a href=\"https://ttm.financial/S/REGN\">$Regeneron Pharmaceuticals(REGN)$</a> and <a href=\"https://ttm.financial/S/VRTX\">$Vertex Pharmaceuticals(VRTX)$</a> hit new high of $853.97 and $374.45 respectively. <a href=\"https://ttm.financial/S/REGN\">$Regeneron Pharmaceuticals(REGN)$</a> three core value drivers are its eye disease drug Eylea (now available in a high-dose form), immunology drug Dupixent, and anti-cancer therapy Libtayo. FDA approved its high-dose Eylea&nbsp;in August.&nbsp; <a href=\"https://ttm.financial/S/VRTX\">$Vertex Pharmaceuticals(VRTX)$</a> is striving to develop treatments for APOL1-mediated kidney disease, non-opioid pain medications, rare blood disorders, and diabetes.&nbsp;2. Insurance stocks <a href=\"https://ttm.financial/S/ACGL\">$Arch Capital(ACG</a>","listText":"1. Pharma&nbsp;stocks <a href=\"https://ttm.financial/S/REGN\">$Regeneron Pharmaceuticals(REGN)$</a> and <a href=\"https://ttm.financial/S/VRTX\">$Vertex Pharmaceuticals(VRTX)$</a> hit new high of $853.97 and $374.45 respectively. <a href=\"https://ttm.financial/S/REGN\">$Regeneron Pharmaceuticals(REGN)$</a> three core value drivers are its eye disease drug Eylea (now available in a high-dose form), immunology drug Dupixent, and anti-cancer therapy Libtayo. FDA approved its high-dose Eylea&nbsp;in August.&nbsp; <a href=\"https://ttm.financial/S/VRTX\">$Vertex Pharmaceuticals(VRTX)$</a> is striving to develop treatments for APOL1-mediated kidney disease, non-opioid pain medications, rare blood disorders, and diabetes.&nbsp;2. Insurance stocks <a href=\"https://ttm.financial/S/ACGL\">$Arch Capital(ACG</a>","text":"1. Pharma stocks $Regeneron Pharmaceuticals(REGN)$ and $Vertex Pharmaceuticals(VRTX)$ hit new high of $853.97 and $374.45 respectively. $Regeneron Pharmaceuticals(REGN)$ three core value drivers are its eye disease drug Eylea (now available in a high-dose form), immunology drug Dupixent, and anti-cancer therapy Libtayo. FDA approved its high-dose Eylea in August. $Vertex Pharmaceuticals(VRTX)$ is striving to develop treatments for APOL1-mediated kidney disease, non-opioid pain medications, rare blood disorders, and diabetes. 2. Insurance stocks $Arch Capital(ACG","images":[{"img":"https://community-static.tradeup.com/news/aa53ff5d44342e83cb50c0de327a3606","width":"1080","height":"1080"},{"img":"https://community-static.tradeup.com/news/04229662750dc5993d09cdf1195f49aa","width":"560","height":"240"},{"img":"https://community-static.tradeup.com/news/ef71f50c18f9da060b0da9a4845269fd","width":"560","height":"240"}],"top":1,"highlighted":1,"essential":2,"paper":2,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/231579639484416","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":5,"langContent":"EN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":349,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":232186425647168,"gmtCreate":1697714388689,"gmtModify":1697714490482,"author":{"id":"3575340533089136","authorId":"3575340533089136","name":"Sen lim","avatar":"https://community-static.tradeup.com/news/8c0dcc765f505fe12d0f172a1ff04c50","crmLevel":1,"crmLevelSwitch":1,"followedFlag":false,"idStr":"3575340533089136","authorIdStr":"3575340533089136"},"themes":[],"htmlText":"Great ariticle, would you like to share it?","listText":"Great ariticle, would you like to share it?","text":"Great ariticle, would you like to share it?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/232186425647168","repostId":"231561002254464","repostType":1,"repost":{"id":231561002254464,"gmtCreate":1697542503013,"gmtModify":1697542508953,"author":{"id":"3570103090255456","authorId":"3570103090255456","name":"JC888","avatar":"https://community-static.tradeup.com/news/f3e3c0218599fca5c4e265ddbee1fb32","crmLevel":4,"crmLevelSwitch":1,"followedFlag":false,"idStr":"3570103090255456","authorIdStr":"3570103090255456"},"themes":[],"title":"$BAC Q3 earnings out & there's NOTHING to celebrate.","htmlText":"On Fri, 13 Oct 2023 — <a href=\"https://ttm.financial/S/JPM\">$JPMorgan Chase(JPM)$</a>, <a href=\"https://ttm.financial/S/WFC\">$Wells Fargo(WFC)$</a> and <a href=\"https://ttm.financial/S/C\">$Citigroup(C)$</a> have released their Q3 2023 earnings. Despite all the challenges faced by the financial sector, the 3 banks managed to report profits. JPMorgan Chase &amp; Co. reported a profit of $13.15 billion, or $4.33 a share, YoY. Wells Fargo &amp; Company reported a profit of $6.04 billion, or $1.38 a share, YoY. Citigroup Inc.reported a profit of $5.2 billion, or $2.85 a share, YoY. On Tue, 17 Oct 2023 <a href=\"https://ttm.financial/S/BAC\">$Bank of America(BAC)$</a> will be reporting its Q3 2023 quarterly earnings. I came across a post by Barron (see below), that I think is insightful and remind","listText":"On Fri, 13 Oct 2023 — <a href=\"https://ttm.financial/S/JPM\">$JPMorgan Chase(JPM)$</a>, <a href=\"https://ttm.financial/S/WFC\">$Wells Fargo(WFC)$</a> and <a href=\"https://ttm.financial/S/C\">$Citigroup(C)$</a> have released their Q3 2023 earnings. Despite all the challenges faced by the financial sector, the 3 banks managed to report profits. JPMorgan Chase &amp; Co. reported a profit of $13.15 billion, or $4.33 a share, YoY. Wells Fargo &amp; Company reported a profit of $6.04 billion, or $1.38 a share, YoY. Citigroup Inc.reported a profit of $5.2 billion, or $2.85 a share, YoY. On Tue, 17 Oct 2023 <a href=\"https://ttm.financial/S/BAC\">$Bank of America(BAC)$</a> will be reporting its Q3 2023 quarterly earnings. I came across a post by Barron (see below), that I think is insightful and remind","text":"On Fri, 13 Oct 2023 — $JPMorgan Chase(JPM)$, $Wells Fargo(WFC)$ and $Citigroup(C)$ have released their Q3 2023 earnings. Despite all the challenges faced by the financial sector, the 3 banks managed to report profits. JPMorgan Chase & Co. reported a profit of $13.15 billion, or $4.33 a share, YoY. Wells Fargo & Company reported a profit of $6.04 billion, or $1.38 a share, YoY. Citigroup Inc.reported a profit of $5.2 billion, or $2.85 a share, YoY. On Tue, 17 Oct 2023 $Bank of America(BAC)$ will be reporting its Q3 2023 quarterly earnings. I came across a post by Barron (see below), that I think is insightful and remind","images":[{"img":"https://community-static.tradeup.com/news/9beb8514a911c8de816f758e920b284a","width":"1756","height":"187"},{"img":"https://community-static.tradeup.com/news/8bd8043ab186d4de0a20ff096e8edb1f","width":"709","height":"170"},{"img":"https://community-static.tradeup.com/news/984fd62ee14572ac97c40adae7f54016","width":"1149","height":"342"}],"top":1,"highlighted":2,"essential":2,"paper":2,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/231561002254464","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":5,"langContent":"EN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":160,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":232186342195360,"gmtCreate":1697714376485,"gmtModify":1697714490494,"author":{"id":"3575340533089136","authorId":"3575340533089136","name":"Sen lim","avatar":"https://community-static.tradeup.com/news/8c0dcc765f505fe12d0f172a1ff04c50","crmLevel":1,"crmLevelSwitch":1,"followedFlag":false,"idStr":"3575340533089136","authorIdStr":"3575340533089136"},"themes":[],"htmlText":"Great ariticle, would you like to share it?","listText":"Great ariticle, would you like to share it?","text":"Great ariticle, would you like to share it?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/232186342195360","repostId":"231606594916440","repostType":1,"repost":{"id":231606594916440,"gmtCreate":1697553625415,"gmtModify":1697554123876,"author":{"id":"3572212908677301","authorId":"3572212908677301","name":"TigerOptions","avatar":"https://community-static.tradeup.com/news/20925853481806adc78dcdfe25f2fe89","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3572212908677301","authorIdStr":"3572212908677301"},"themes":[],"title":"Celebrating BAC's Earnings with Strangle 🎉","htmlText":"Hello, fellow tigers! Today, I want to share how I celebrated <a href=\"https://ttm.financial/S/BAC\">$Bank of America(BAC)$</a> recent third-quarter earnings report with a well-timed strangle position. Q3 Highlights In the third quarter, BAC reported earnings per share (EPS) of $0.90, surpassing the analyst consensus estimate of $0.83. Additionally, the bank's revenue for the quarter came in at $25.2 billion, slightly ahead of the consensus estimate of $25.13 billion. These impressive results provided a strong foundation for my investment strategy. BAC Daily Chart With the stock price that closed at $26.99, it's important to note that BAC had faced some challenges, with a -14.83% decline over the last three months and a -22.62% dip in the past year. Despite these hurdles, I saw an opportuni","listText":"Hello, fellow tigers! Today, I want to share how I celebrated <a href=\"https://ttm.financial/S/BAC\">$Bank of America(BAC)$</a> recent third-quarter earnings report with a well-timed strangle position. Q3 Highlights In the third quarter, BAC reported earnings per share (EPS) of $0.90, surpassing the analyst consensus estimate of $0.83. Additionally, the bank's revenue for the quarter came in at $25.2 billion, slightly ahead of the consensus estimate of $25.13 billion. These impressive results provided a strong foundation for my investment strategy. BAC Daily Chart With the stock price that closed at $26.99, it's important to note that BAC had faced some challenges, with a -14.83% decline over the last three months and a -22.62% dip in the past year. Despite these hurdles, I saw an opportuni","text":"Hello, fellow tigers! Today, I want to share how I celebrated $Bank of America(BAC)$ recent third-quarter earnings report with a well-timed strangle position. Q3 Highlights In the third quarter, BAC reported earnings per share (EPS) of $0.90, surpassing the analyst consensus estimate of $0.83. Additionally, the bank's revenue for the quarter came in at $25.2 billion, slightly ahead of the consensus estimate of $25.13 billion. These impressive results provided a strong foundation for my investment strategy. BAC Daily Chart With the stock price that closed at $26.99, it's important to note that BAC had faced some challenges, with a -14.83% decline over the last three months and a -22.62% dip in the past year. Despite these hurdles, I saw an opportuni","images":[{"img":"https://community-static.tradeup.com/news/b0ac3b4e8d787ba8d4dc11d02b3e1dee","width":"362","height":"604"}],"top":1,"highlighted":2,"essential":2,"paper":2,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/231606594916440","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":4,"langContent":"EN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":406,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9955582699,"gmtCreate":1675563766712,"gmtModify":1676539007789,"author":{"id":"3575340533089136","authorId":"3575340533089136","name":"Sen lim","avatar":"https://community-static.tradeup.com/news/8c0dcc765f505fe12d0f172a1ff04c50","crmLevel":1,"crmLevelSwitch":1,"followedFlag":false,"idStr":"3575340533089136","authorIdStr":"3575340533089136"},"themes":[],"htmlText":"ORGS - orgenesis&nbsp; MASI - masimo corporation","listText":"ORGS - orgenesis&nbsp; MASI - masimo corporation","text":"ORGS - orgenesis MASI - masimo corporation","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9955582699","isVote":1,"tweetType":1,"viewCount":371,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"hots":[{"id":9955582699,"gmtCreate":1675563766712,"gmtModify":1676539007789,"author":{"id":"3575340533089136","authorId":"3575340533089136","name":"Sen lim","avatar":"https://community-static.tradeup.com/news/8c0dcc765f505fe12d0f172a1ff04c50","crmLevel":1,"crmLevelSwitch":1,"followedFlag":false,"idStr":"3575340533089136","authorIdStr":"3575340533089136"},"themes":[],"htmlText":"ORGS - orgenesis&nbsp; MASI - masimo corporation","listText":"ORGS - orgenesis&nbsp; MASI - masimo corporation","text":"ORGS - orgenesis MASI - masimo corporation","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9955582699","isVote":1,"tweetType":1,"viewCount":371,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":256917102407696,"gmtCreate":1703757916604,"gmtModify":1703757919870,"author":{"id":"3575340533089136","authorId":"3575340533089136","name":"Sen lim","avatar":"https://community-static.tradeup.com/news/8c0dcc765f505fe12d0f172a1ff04c50","crmLevel":1,"crmLevelSwitch":1,"followedFlag":false,"idStr":"3575340533089136","authorIdStr":"3575340533089136"},"themes":[],"htmlText":"The story will unfold brilliantly in 2024","listText":"The story will unfold brilliantly in 2024","text":"The story will unfold brilliantly in 2024","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/256917102407696","repostId":"256901342552192","repostType":1,"repost":{"id":256901342552192,"gmtCreate":1703749619270,"gmtModify":1703749647446,"author":{"id":"3527667631258507","authorId":"3527667631258507","name":"VideoLounge","avatar":"https://static.tigerbbs.com/d2c50ee53d2487e186b3c414f8529d52","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3527667631258507","authorIdStr":"3527667631258507"},"themes":[],"htmlText":"\n \n \n  [The Fed has the economy's back in 2024, says Wharton's Jeremy Siegel] Jeremy Siegel, Wharton Professor, joins 'Closing Bell' to discuss the markets, equities and his Fed outlook. <a href=\"https://ttm.financial/S/.SPX\">$S&amp;P 500(.SPX)$</a>\n \n","listText":"[The Fed has the economy's back in 2024, says Wharton's Jeremy Siegel] Jeremy Siegel, Wharton Professor, joins 'Closing Bell' to discuss the markets, equities and his Fed outlook. <a href=\"https://ttm.financial/S/.SPX\">$S&amp;P 500(.SPX)$</a>","text":"[The Fed has the economy's back in 2024, says Wharton's Jeremy Siegel] Jeremy Siegel, Wharton Professor, joins 'Closing Bell' to discuss the markets, equities and his Fed outlook. $S&P 500(.SPX)$","images":[],"top":1,"highlighted":1,"essential":2,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/256901342552192","isVote":1,"tweetType":2,"object":{"id":"1bc999e668f64d2585532868777ae90c","tweetId":"256901342552192","videoUrl":"https://1254107296.vod2.myqcloud.com/e2ad4227vodcq1254107296/185c5d1b3270835014349635313/f0.mp4","poster":"https://community-static.tradeup.com/news/8074bcf4d3448aeb6fe42f69c5f6f100"},"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":238,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":232186656051360,"gmtCreate":1697714453110,"gmtModify":1697714800230,"author":{"id":"3575340533089136","authorId":"3575340533089136","name":"Sen lim","avatar":"https://community-static.tradeup.com/news/8c0dcc765f505fe12d0f172a1ff04c50","crmLevel":1,"crmLevelSwitch":1,"followedFlag":false,"idStr":"3575340533089136","authorIdStr":"3575340533089136"},"themes":[],"htmlText":"","listText":"","text":"","images":[{"img":"https://community-static.tradeup.com/news/d737c0e83a2ca20db6a3f699381bb310","width":"1170","height":"3054"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/232186656051360","isVote":1,"tweetType":1,"viewCount":208,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":232186431336688,"gmtCreate":1697714398564,"gmtModify":1697714490534,"author":{"id":"3575340533089136","authorId":"3575340533089136","name":"Sen lim","avatar":"https://community-static.tradeup.com/news/8c0dcc765f505fe12d0f172a1ff04c50","crmLevel":1,"crmLevelSwitch":1,"followedFlag":false,"idStr":"3575340533089136","authorIdStr":"3575340533089136"},"themes":[],"htmlText":"Great ariticle, would you like to share it?","listText":"Great ariticle, would you like to share it?","text":"Great ariticle, would you like to share it?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/232186431336688","repostId":"231579639484416","repostType":1,"repost":{"id":231579639484416,"gmtCreate":1697546525532,"gmtModify":1697546571385,"author":{"id":"9000000000000419","authorId":"9000000000000419","name":"WallStreet_Tiger","avatar":"https://community-static.tradeup.com/news/1fdbba25bcf5dea3f281241ba1320d10","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"9000000000000419","authorIdStr":"9000000000000419"},"themes":[],"title":"Pharma and Insurance Stocks Hit New Highs With Earnings Beats and Analysts Upgrade!","htmlText":"1. Pharma&nbsp;stocks <a href=\"https://ttm.financial/S/REGN\">$Regeneron Pharmaceuticals(REGN)$</a> and <a href=\"https://ttm.financial/S/VRTX\">$Vertex Pharmaceuticals(VRTX)$</a> hit new high of $853.97 and $374.45 respectively. <a href=\"https://ttm.financial/S/REGN\">$Regeneron Pharmaceuticals(REGN)$</a> three core value drivers are its eye disease drug Eylea (now available in a high-dose form), immunology drug Dupixent, and anti-cancer therapy Libtayo. FDA approved its high-dose Eylea&nbsp;in August.&nbsp; <a href=\"https://ttm.financial/S/VRTX\">$Vertex Pharmaceuticals(VRTX)$</a> is striving to develop treatments for APOL1-mediated kidney disease, non-opioid pain medications, rare blood disorders, and diabetes.&nbsp;2. Insurance stocks <a href=\"https://ttm.financial/S/ACGL\">$Arch Capital(ACG</a>","listText":"1. Pharma&nbsp;stocks <a href=\"https://ttm.financial/S/REGN\">$Regeneron Pharmaceuticals(REGN)$</a> and <a href=\"https://ttm.financial/S/VRTX\">$Vertex Pharmaceuticals(VRTX)$</a> hit new high of $853.97 and $374.45 respectively. <a href=\"https://ttm.financial/S/REGN\">$Regeneron Pharmaceuticals(REGN)$</a> three core value drivers are its eye disease drug Eylea (now available in a high-dose form), immunology drug Dupixent, and anti-cancer therapy Libtayo. FDA approved its high-dose Eylea&nbsp;in August.&nbsp; <a href=\"https://ttm.financial/S/VRTX\">$Vertex Pharmaceuticals(VRTX)$</a> is striving to develop treatments for APOL1-mediated kidney disease, non-opioid pain medications, rare blood disorders, and diabetes.&nbsp;2. Insurance stocks <a href=\"https://ttm.financial/S/ACGL\">$Arch Capital(ACG</a>","text":"1. Pharma stocks $Regeneron Pharmaceuticals(REGN)$ and $Vertex Pharmaceuticals(VRTX)$ hit new high of $853.97 and $374.45 respectively. $Regeneron Pharmaceuticals(REGN)$ three core value drivers are its eye disease drug Eylea (now available in a high-dose form), immunology drug Dupixent, and anti-cancer therapy Libtayo. FDA approved its high-dose Eylea in August. $Vertex Pharmaceuticals(VRTX)$ is striving to develop treatments for APOL1-mediated kidney disease, non-opioid pain medications, rare blood disorders, and diabetes. 2. Insurance stocks $Arch Capital(ACG","images":[{"img":"https://community-static.tradeup.com/news/aa53ff5d44342e83cb50c0de327a3606","width":"1080","height":"1080"},{"img":"https://community-static.tradeup.com/news/04229662750dc5993d09cdf1195f49aa","width":"560","height":"240"},{"img":"https://community-static.tradeup.com/news/ef71f50c18f9da060b0da9a4845269fd","width":"560","height":"240"}],"top":1,"highlighted":1,"essential":2,"paper":2,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/231579639484416","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":5,"langContent":"EN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":349,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":232186425647168,"gmtCreate":1697714388689,"gmtModify":1697714490482,"author":{"id":"3575340533089136","authorId":"3575340533089136","name":"Sen lim","avatar":"https://community-static.tradeup.com/news/8c0dcc765f505fe12d0f172a1ff04c50","crmLevel":1,"crmLevelSwitch":1,"followedFlag":false,"idStr":"3575340533089136","authorIdStr":"3575340533089136"},"themes":[],"htmlText":"Great ariticle, would you like to share it?","listText":"Great ariticle, would you like to share it?","text":"Great ariticle, would you like to share it?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/232186425647168","repostId":"231561002254464","repostType":1,"repost":{"id":231561002254464,"gmtCreate":1697542503013,"gmtModify":1697542508953,"author":{"id":"3570103090255456","authorId":"3570103090255456","name":"JC888","avatar":"https://community-static.tradeup.com/news/f3e3c0218599fca5c4e265ddbee1fb32","crmLevel":4,"crmLevelSwitch":1,"followedFlag":false,"idStr":"3570103090255456","authorIdStr":"3570103090255456"},"themes":[],"title":"$BAC Q3 earnings out & there's NOTHING to celebrate.","htmlText":"On Fri, 13 Oct 2023 — <a href=\"https://ttm.financial/S/JPM\">$JPMorgan Chase(JPM)$</a>, <a href=\"https://ttm.financial/S/WFC\">$Wells Fargo(WFC)$</a> and <a href=\"https://ttm.financial/S/C\">$Citigroup(C)$</a> have released their Q3 2023 earnings. Despite all the challenges faced by the financial sector, the 3 banks managed to report profits. JPMorgan Chase &amp; Co. reported a profit of $13.15 billion, or $4.33 a share, YoY. Wells Fargo &amp; Company reported a profit of $6.04 billion, or $1.38 a share, YoY. Citigroup Inc.reported a profit of $5.2 billion, or $2.85 a share, YoY. On Tue, 17 Oct 2023 <a href=\"https://ttm.financial/S/BAC\">$Bank of America(BAC)$</a> will be reporting its Q3 2023 quarterly earnings. I came across a post by Barron (see below), that I think is insightful and remind","listText":"On Fri, 13 Oct 2023 — <a href=\"https://ttm.financial/S/JPM\">$JPMorgan Chase(JPM)$</a>, <a href=\"https://ttm.financial/S/WFC\">$Wells Fargo(WFC)$</a> and <a href=\"https://ttm.financial/S/C\">$Citigroup(C)$</a> have released their Q3 2023 earnings. Despite all the challenges faced by the financial sector, the 3 banks managed to report profits. JPMorgan Chase &amp; Co. reported a profit of $13.15 billion, or $4.33 a share, YoY. Wells Fargo &amp; Company reported a profit of $6.04 billion, or $1.38 a share, YoY. Citigroup Inc.reported a profit of $5.2 billion, or $2.85 a share, YoY. On Tue, 17 Oct 2023 <a href=\"https://ttm.financial/S/BAC\">$Bank of America(BAC)$</a> will be reporting its Q3 2023 quarterly earnings. I came across a post by Barron (see below), that I think is insightful and remind","text":"On Fri, 13 Oct 2023 — $JPMorgan Chase(JPM)$, $Wells Fargo(WFC)$ and $Citigroup(C)$ have released their Q3 2023 earnings. Despite all the challenges faced by the financial sector, the 3 banks managed to report profits. JPMorgan Chase & Co. reported a profit of $13.15 billion, or $4.33 a share, YoY. Wells Fargo & Company reported a profit of $6.04 billion, or $1.38 a share, YoY. Citigroup Inc.reported a profit of $5.2 billion, or $2.85 a share, YoY. On Tue, 17 Oct 2023 $Bank of America(BAC)$ will be reporting its Q3 2023 quarterly earnings. I came across a post by Barron (see below), that I think is insightful and remind","images":[{"img":"https://community-static.tradeup.com/news/9beb8514a911c8de816f758e920b284a","width":"1756","height":"187"},{"img":"https://community-static.tradeup.com/news/8bd8043ab186d4de0a20ff096e8edb1f","width":"709","height":"170"},{"img":"https://community-static.tradeup.com/news/984fd62ee14572ac97c40adae7f54016","width":"1149","height":"342"}],"top":1,"highlighted":2,"essential":2,"paper":2,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/231561002254464","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":5,"langContent":"EN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":160,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":232186342195360,"gmtCreate":1697714376485,"gmtModify":1697714490494,"author":{"id":"3575340533089136","authorId":"3575340533089136","name":"Sen lim","avatar":"https://community-static.tradeup.com/news/8c0dcc765f505fe12d0f172a1ff04c50","crmLevel":1,"crmLevelSwitch":1,"followedFlag":false,"idStr":"3575340533089136","authorIdStr":"3575340533089136"},"themes":[],"htmlText":"Great ariticle, would you like to share it?","listText":"Great ariticle, would you like to share it?","text":"Great ariticle, would you like to share it?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/232186342195360","repostId":"231606594916440","repostType":1,"repost":{"id":231606594916440,"gmtCreate":1697553625415,"gmtModify":1697554123876,"author":{"id":"3572212908677301","authorId":"3572212908677301","name":"TigerOptions","avatar":"https://community-static.tradeup.com/news/20925853481806adc78dcdfe25f2fe89","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3572212908677301","authorIdStr":"3572212908677301"},"themes":[],"title":"Celebrating BAC's Earnings with Strangle 🎉","htmlText":"Hello, fellow tigers! Today, I want to share how I celebrated <a href=\"https://ttm.financial/S/BAC\">$Bank of America(BAC)$</a> recent third-quarter earnings report with a well-timed strangle position. Q3 Highlights In the third quarter, BAC reported earnings per share (EPS) of $0.90, surpassing the analyst consensus estimate of $0.83. Additionally, the bank's revenue for the quarter came in at $25.2 billion, slightly ahead of the consensus estimate of $25.13 billion. These impressive results provided a strong foundation for my investment strategy. BAC Daily Chart With the stock price that closed at $26.99, it's important to note that BAC had faced some challenges, with a -14.83% decline over the last three months and a -22.62% dip in the past year. Despite these hurdles, I saw an opportuni","listText":"Hello, fellow tigers! Today, I want to share how I celebrated <a href=\"https://ttm.financial/S/BAC\">$Bank of America(BAC)$</a> recent third-quarter earnings report with a well-timed strangle position. Q3 Highlights In the third quarter, BAC reported earnings per share (EPS) of $0.90, surpassing the analyst consensus estimate of $0.83. Additionally, the bank's revenue for the quarter came in at $25.2 billion, slightly ahead of the consensus estimate of $25.13 billion. These impressive results provided a strong foundation for my investment strategy. BAC Daily Chart With the stock price that closed at $26.99, it's important to note that BAC had faced some challenges, with a -14.83% decline over the last three months and a -22.62% dip in the past year. Despite these hurdles, I saw an opportuni","text":"Hello, fellow tigers! Today, I want to share how I celebrated $Bank of America(BAC)$ recent third-quarter earnings report with a well-timed strangle position. Q3 Highlights In the third quarter, BAC reported earnings per share (EPS) of $0.90, surpassing the analyst consensus estimate of $0.83. Additionally, the bank's revenue for the quarter came in at $25.2 billion, slightly ahead of the consensus estimate of $25.13 billion. These impressive results provided a strong foundation for my investment strategy. BAC Daily Chart With the stock price that closed at $26.99, it's important to note that BAC had faced some challenges, with a -14.83% decline over the last three months and a -22.62% dip in the past year. Despite these hurdles, I saw an opportuni","images":[{"img":"https://community-static.tradeup.com/news/b0ac3b4e8d787ba8d4dc11d02b3e1dee","width":"362","height":"604"}],"top":1,"highlighted":2,"essential":2,"paper":2,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/231606594916440","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":4,"langContent":"EN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":406,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"lives":[]}